News

BU Rheumatology at the 2022 Arthritis Foundation’s Walk to Cure Arthritis

 

 

 

 

 


Enjoy these pictures and comments, shared with us by Tuhina Neogi, from the Arthritis Foundation walk on Sunday, June 12.

We lucked out with great weather. We had the best sign and the best turn out. We didn’t take enough pictures, though. We missed taking pics of some members of the team, and missed out on some important photo-ops, particularly with our youngest walkers. We had a good number in the 3-&-under age group…which made our walk quite leisurely and punctuated…

The waffles with whipped cream and fruit were a hit, and the kids got some great tattoos; some held on to helium-filled balloons for a short time before they inevitably accidentally let go.

Some thanks are in order:

- Thank you to Gabriela for being a great Team Leader, making sure the group stopped periodically to ensure that none of our crew at the back of the pack were having any difficulty (particularly as some young walkers got distracted by geese with their baby goslings or thorny weeds, etc.)

- Thank you to Kim for setting up our team online

- Thank you to Sharon, Anne, and Lisa for overseeing the logistics of our sign and brochures

- Thank you to Jean for bringing snacks for our table

- Thank you to all that came out!

 

It was great to see everyone, and hopefully we can go back to making this an annual get together with family.

Snapshots from the 2022 OARSI Meeting in Berlin

loading slideshow...

  • Award Ceremony

    Tuhina Neogi received the 2022 OARSI Clinical Trial Award

  • Oral Presentation

    Jean Liew presenting her oral abstract

  • Oral Presentation

    Deepak Kumar's oral abstract presentation

  • Oral Presentation

    Reza Jafarzadeh, presenting his oral abstract

  • Virtual Attendees Michael Rose and Soyoung Lee

    Michael and Soyoung attending the meeting virtually, in Boston. Michael's abstract was chosen as one of the highest scoring abstracts

  • Batman (Farshid Guilak) and Catwoman (Tuhina Neogi) facing off for the Great Debate

    Plenary Session - Debate: Symptoms or Structure: What Should Be Our Target in OA?

  • Farshid Guilak and Tuhina Neogi ready for the Great Debate

    Plenary Session - Debate: Symptoms or Structure: What Should Be Our Target in OA?

  • Farshid Guilak and Tuhina Neogi in the Great Debate

    Plenary Session - Debate: Symptoms or Structure: What Should Be Our Target in OA?

  • Tuhina, Jean and Deepak attending a session

  • Deepak and Jean attending a session

  • Sightseeing!

    Jean and Tuhina taking in the sights in Berlin

Tuhina Neogi receives the 2022 OARSI Clinical Research Award

Tuhina Neogi is the recipient of the 2022 Clinical Research Award from the Osteoarthritis Research Society International.

The purpose of the OARSI Clinical Research Award is to recognize excellence in clinical research related to osteoarthritis. Research domains include, but are not limited to, areas such as epidemiology and health services research, clinical outcomes, translational research, and therapeutics, encompassing all phases of research having clinical implications; research having been conducted within the last five years.

Dr. Neogi was acknowledged during the Opening  Ceremony at the World Congress on April 7, 2022 in Berlin.

More News from OARSI 2022

From Healio Rheumatology, April 11 issue

Increasing rates of walking, standing or maximum-level activity is associated with reductions in cartilage loss in knee osteoarthritis, according to a speaker at the 2022 OARSI World Congress.

“Physical activity is consistently recommended for managing knee OA,” S. Reza Jafarzadeh, PhD, of the Boston University School of Medicine, said in his presentation.

Reza Jafarzadeh, DVM, MPVM, PhD is an Assistant Professor and Director of the Clinical Research & Data Analysis Core in the Section of Rheumatology. He presented his poster in a plenary session during the OARSI 2022 World Congress on Osteoarthritis in Berlin, Germany.

Read the article

News from OARSI 2022

From Healio Rheumatology April 8, 2022 issue

Wearable devices demonstrate strong reliability in assessing gait and standing speed in the homes of patients with osteoarthritis, according to findings presented at the 2022 OARSI World Congress.

Wearable technologies to assess disease parameters and outcomes in patient homes have been gaining more widespread use in rheumatology in recent years, partly due to the COVID-19 pandemic, according to Michael J. Rose, BS, of Boston University.

Michael J. Rose, BS, a member of Deepak Kumar's Movement & Applied Imaging Lab at Sargent College, presented virtually his poster at the OARSI 2022 World Congress on Osteoarthritis, held in Berlin. His abstract, Reliability of Wearable Sensors for Assessing Gait and Chair Stand Function at Home in People with Knee Osteoarthritis, was presented during a plenary session of the highest score abstracts submitted.

Read the article

In Healio Rheumatology: James O’Dell and Tuhina Neogi on the debate on gout treatment

From the February 25, 2022 issue of Healio Rheumatology

'Horribly mismanaged': Debate over gout treatment rages as cases surge

According to Tuhina Neogi, MD, PhD, professor of medicine and of epidemiology, Alan S. Cohen professor of rheumatology, and chief of rheumatology at the Boston University School of Medicine and Boston Medical Center, gout has been on the rise particularly in developed countries.

Neogi_Tuhina_2022

Tuhina Neogi

“The Global Burden of Disease Study provides some insights about what may be contributing to the doubling of the prevalence of gout in just under 30 years,” Neogi told Healio. “There has been a rise in the global population and increase in life expectancy over that time, but that alone is not sufficient to explain this dramatic increase in gout prevalence.”

 

Read the article

Healio Interview: James O’Dell and Tuhina Neogi on the rising prevalence and mismanagement of gout

Healio Rheumatology article:

'Horribly mismanaged': Debate over gout treatment rages as cases surge

All around the world, gout prevalence is growing at an alarming pace, while gout treatment remains as “horribly mismanaged” as ever.

In this article James ODell, MD, Robert L. Grissom Professor of Internal Medicine and Vice Chair and Chief of Rheumatology at the University of Nebraska Medical Center, in Omaha and Tuhina Neogi, MD, PhD, Professor of Medicine and of Epidemiology, Alan S. Cohen Professor of Rheumatology, and Chief of Rheumatology at the Boston University School of Medicine and Boston Medical Center discuss the alarming growth of the prevalence of gout and the mismanagement in its treatment.

Read the full article

Healio on Twitter: @GoHelio